MOMA Therapeutics Completes $150 Million Series B Financing
MOMA Therapeutics is an American molecular machine drug discovery platform developer dedicated to the development of next-generation precision medicines by targeting molecular machines for human diseases. MOMA has not announced any developable targets, but has disclosed that it modulates cystic fibrosis (CF) The concept of research and development of transporter drugs has further announced its […]
MOMA Therapeutics Completes $150 Million Series B Financing Read More »